UniProt ID | BRX1_HUMAN | |
---|---|---|
UniProt AC | Q8TDN6 | |
Protein Name | Ribosome biogenesis protein BRX1 homolog | |
Gene Name | BRIX1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 353 | |
Subcellular Localization | Nucleus, nucleolus. | |
Protein Description | Required for biogenesis of the 60S ribosomal subunit.. | |
Protein Sequence | MAATKRKRRGGFAVQAKKPKRNEIDAEPPAKRHATAEEVEEEERDRIPGPVCKGKWKNKERILIFSSRGINFRTRHLMQDLRMLMPHSKADTKMDRKDKLFVINEVCEMKNCNKCIYFEAKKKQDLYMWLSNSPHGPSAKFLVQNIHTLAELKMTGNCLKGSRPLLSFDPAFDELPHYALLKELLIQIFSTPRYHPKSQPFVDHVFTFTILDNRIWFRNFQIIEEDAALVEIGPRFVLNLIKIFQGSFGGPTLYENPHYQSPNMHRRVIRSITAAKYREKQQVKDVQKLRKKEPKTLLPHDPTADVFVTPAEEKPIEIQWVKPEPKVDLKARKKRIYKRQRKMKQRMDSGKTK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
9 | Methylation | AATKRKRRGGFAVQA CCCCCCCCCCCCEEE | 53.25 | - | |
17 | Acetylation | GGFAVQAKKPKRNEI CCCCEEECCCCCCCC | 53.14 | 25953088 | |
18 | Acetylation | GFAVQAKKPKRNEID CCCEEECCCCCCCCC | 59.80 | 25953088 | |
31 | 2-Hydroxyisobutyrylation | IDAEPPAKRHATAEE CCCCCCHHHCCCHHH | 50.95 | - | |
31 | Ubiquitination | IDAEPPAKRHATAEE CCCCCCHHHCCCHHH | 50.95 | 24816145 | |
31 | Acetylation | IDAEPPAKRHATAEE CCCCCCHHHCCCHHH | 50.95 | 25953088 | |
35 | Phosphorylation | PPAKRHATAEEVEEE CCHHHCCCHHHHHHH | 28.60 | 23312004 | |
53 | Ubiquitination | RIPGPVCKGKWKNKE CCCCCCCCCCCCCCC | 64.85 | 32015554 | |
53 | Acetylation | RIPGPVCKGKWKNKE CCCCCCCCCCCCCCC | 64.85 | 26051181 | |
82 | Methylation | RHLMQDLRMLMPHSK HHHHHHHHHHCCCCC | 25.20 | - | |
89 | Acetylation | RMLMPHSKADTKMDR HHHCCCCCCCCCCCC | 47.44 | 26051181 | |
99 | 2-Hydroxyisobutyrylation | TKMDRKDKLFVINEV CCCCCCCCEEEEEHH | 47.03 | - | |
99 | Acetylation | TKMDRKDKLFVINEV CCCCCCCCEEEEEHH | 47.03 | 26051181 | |
109 | Sulfoxidation | VINEVCEMKNCNKCI EEEHHHHHCCCCCCE | 2.98 | 21406390 | |
110 | Acetylation | INEVCEMKNCNKCIY EEHHHHHCCCCCCEE | 35.73 | 26051181 | |
114 | Acetylation | CEMKNCNKCIYFEAK HHHCCCCCCEEEEEC | 24.98 | 26051181 | |
121 | Acetylation | KCIYFEAKKKQDLYM CCEEEEECCHHCEEH | 53.99 | 25953088 | |
123 | 2-Hydroxyisobutyrylation | IYFEAKKKQDLYMWL EEEEECCHHCEEHHH | 48.62 | - | |
127 | Phosphorylation | AKKKQDLYMWLSNSP ECCHHCEEHHHHCCC | 8.44 | 17360941 | |
131 | Phosphorylation | QDLYMWLSNSPHGPS HCEEHHHHCCCCCHH | 21.54 | 21406692 | |
133 | Phosphorylation | LYMWLSNSPHGPSAK EEHHHHCCCCCHHHH | 18.20 | 21406692 | |
138 | Phosphorylation | SNSPHGPSAKFLVQN HCCCCCHHHHHHHHC | 49.00 | 21406692 | |
153 | Acetylation | IHTLAELKMTGNCLK HHHHHHHEHHCCCCC | 26.39 | 26051181 | |
153 | Ubiquitination | IHTLAELKMTGNCLK HHHHHHHEHHCCCCC | 26.39 | 29967540 | |
160 | Acetylation | KMTGNCLKGSRPLLS EHHCCCCCCCCCCCC | 57.97 | 26051181 | |
160 | Sumoylation | KMTGNCLKGSRPLLS EHHCCCCCCCCCCCC | 57.97 | 28112733 | |
162 | Phosphorylation | TGNCLKGSRPLLSFD HCCCCCCCCCCCCCC | 29.19 | 21406692 | |
167 | Phosphorylation | KGSRPLLSFDPAFDE CCCCCCCCCCCCCCC | 34.97 | 21406692 | |
178 | Phosphorylation | AFDELPHYALLKELL CCCCCCHHHHHHHHH | 9.30 | 21406692 | |
197 | Acetylation | STPRYHPKSQPFVDH CCCCCCCCCCCCCCE | 48.70 | 26051181 | |
247 | Phosphorylation | LIKIFQGSFGGPTLY HHHHHCCCCCCCCCC | 15.22 | 24732914 | |
252 | Phosphorylation | QGSFGGPTLYENPHY CCCCCCCCCCCCCCC | 45.29 | 23927012 | |
254 | Phosphorylation | SFGGPTLYENPHYQS CCCCCCCCCCCCCCC | 19.01 | 23927012 | |
259 | Phosphorylation | TLYENPHYQSPNMHR CCCCCCCCCCCHHHH | 16.37 | 23927012 | |
261 | Phosphorylation | YENPHYQSPNMHRRV CCCCCCCCCHHHHHH | 15.86 | 23401153 | |
271 | Phosphorylation | MHRRVIRSITAAKYR HHHHHHHHHHHHHHH | 17.11 | 28555341 | |
276 | Acetylation | IRSITAAKYREKQQV HHHHHHHHHHHHHHH | 42.23 | 19608861 | |
276 | 2-Hydroxyisobutyrylation | IRSITAAKYREKQQV HHHHHHHHHHHHHHH | 42.23 | - | |
276 | Ubiquitination | IRSITAAKYREKQQV HHHHHHHHHHHHHHH | 42.23 | 19608861 | |
284 | Ubiquitination | YREKQQVKDVQKLRK HHHHHHHHHHHHHHH | 48.09 | 24816145 | |
303 | Phosphorylation | TLLPHDPTADVFVTP CCCCCCCCCCEEEEC | 41.36 | 23898821 | |
309 | Phosphorylation | PTADVFVTPAEEKPI CCCCEEEECCCCCCE | 12.81 | 27422710 | |
314 | Sumoylation | FVTPAEEKPIEIQWV EEECCCCCCEEEEEC | 42.68 | 28112733 | |
314 | Ubiquitination | FVTPAEEKPIEIQWV EEECCCCCCEEEEEC | 42.68 | 29967540 | |
322 | Neddylation | PIEIQWVKPEPKVDL CEEEEECCCCCCCCH | 40.48 | 32015554 | |
322 | Ubiquitination | PIEIQWVKPEPKVDL CEEEEECCCCCCCCH | 40.48 | 32015554 | |
322 | Sumoylation | PIEIQWVKPEPKVDL CEEEEECCCCCCCCH | 40.48 | 28112733 | |
322 | Sumoylation | PIEIQWVKPEPKVDL CEEEEECCCCCCCCH | 40.48 | - | |
322 | Acetylation | PIEIQWVKPEPKVDL CEEEEECCCCCCCCH | 40.48 | 25953088 | |
326 | Ubiquitination | QWVKPEPKVDLKARK EECCCCCCCCHHHHH | 46.87 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of BRX1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of BRX1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of BRX1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SAE2_HUMAN | UBA2 | physical | 16169070 | |
U119A_HUMAN | UNC119 | physical | 16169070 | |
CD48_HUMAN | CD48 | physical | 16169070 | |
SETB1_HUMAN | SETDB1 | physical | 16169070 | |
RL5_HUMAN | RPL5 | physical | 22939629 | |
EBP2_HUMAN | EBNA1BP2 | physical | 22939629 | |
UTP15_HUMAN | UTP15 | physical | 22939629 | |
DDX56_HUMAN | DDX56 | physical | 26344197 | |
PUM3_HUMAN | KIAA0020 | physical | 26344197 | |
MK67I_HUMAN | NIFK | physical | 26344197 | |
NOC3L_HUMAN | NOC3L | physical | 26344197 | |
NSA2_HUMAN | NSA2 | physical | 26344197 | |
PABP1_HUMAN | PABPC1 | physical | 26344197 | |
PABP3_HUMAN | PABPC3 | physical | 26344197 | |
PABP4_HUMAN | PABPC4 | physical | 26344197 | |
RL10A_HUMAN | RPL10A | physical | 26344197 | |
RL26_HUMAN | RPL26 | physical | 26344197 | |
RL27_HUMAN | RPL27 | physical | 26344197 | |
RL4_HUMAN | RPL4 | physical | 26344197 | |
RL5_HUMAN | RPL5 | physical | 26344197 | |
RL7A_HUMAN | RPL7A | physical | 26344197 | |
RS4X_HUMAN | RPS4X | physical | 26344197 | |
RS7_HUMAN | RPS7 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-276, AND MASS SPECTROMETRY. |